Search clinical trials for: CD19 B cell malignancies
Total 493259 results
-
University Hospital TuebingenCompletedHematologic MalignanciesGermany
-
Washington University School of MedicineRecruitingPediatric Hematologic MalignanciesUnited States
-
Alice BertainaRecruitingHematologic DiseasesUnited States
-
Seattle Children's HospitalRecruitingSoft Tissue Sarcoma | Carcinoma | Osteosarcoma | Ewing Sarcoma | Rhabdoid Tumor | Neuroblastoma | Retinoblastoma | Rhabdomyosarcoma | Wilms Tumor | Hepatoblastoma | Synovial Sarcoma | Desmoplastic Small Round Cell Tumor | Germ Cell Tumor | Pediatric Solid Tumor | Clear Cell Sarcoma | Malignant Peripheral Nerve Sheath TumorsUnited States
-
Peking UniversityShanghai Mingju Biotechnology Co., Ltd.Unknown
-
Second Military Medical UniversityUnknownRecurrent B-Cell Tumor | Refractory B-Cell TumorChina
-
Shandong UniversityJuventas Cell Therapy Ltd.UnknownRelapsed or Refractory Hematological MalignanciesChina
-
Rong TaoNovatim Immune Therapeutics (Zhejiang) Co., Ltd.RecruitingAcute Lymphoblastic Leukemia, in Relapse | B-cell Lymphoma Refractory | B-cell Lymphoma Recurrent | Acute Lymphoblastic Leukemia With Failed RemissionChina
-
He HuangLeman Biotech Co., LtdRecruitingDiffuse Large B-cell LymphomaChina
-
Anhui Provincial HospitalLeman Biotech Co., LtdRecruitingB-cell Acute Lymphoblastic LeukemiaChina
-
Shanghai Ming Ju Biotechnology Co., Ltd.CompletedDiffuse Large B Cell LymphomaChina
-
University of AlbertaAlberta Cancer Foundation; Canadian Cancer Trials GroupRecruitingRelapsed Non Hodgkin Lymphoma | Relapsed Pediatric ALL | Relapsed Adult ALLCanada
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)WithdrawnProgressive Disease | Recurrent B Acute Lymphoblastic Leukemia | Refractory B Acute Lymphoblastic Leukemia | Refractory Chronic Lymphocytic Leukemia | Recurrent Non-Hodgkin Lymphoma | Refractory Non-Hodgkin Lymphoma | Minimal Residual Disease | Recurrent Chronic Lymphocytic Leukemia | CD19 Positive | CD22...United States
-
Chinese PLA General HospitalUnknownRelapsed B-cell Acute Lymphoblastic Leukemia After CD19 CAR-T ACIChina
-
Shanghai General Hospital, Shanghai Jiao Tong University...CompletedAcute Lymphoblastic Leukemia | MRD-positiveChina
-
Eureka Therapeutics Inc.Duke University; Duke Clinical Research InstituteTerminatedLymphomas Non-Hodgkin's B-CellUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI); Food and Drug Administration (FDA)Active, not recruitingRecurrent Glioblastoma | Recurrent Malignant Glioma | Refractory Malignant Glioma | Recurrent WHO Grade III Glioma | Recurrent WHO Grade II Glioma | Refractory Glioblastoma | Refractory WHO Grade II Glioma | Refractory WHO Grade III GliomaUnited States
-
University of Wisconsin, MadisonRecruitingAcute Myeloid Leukemia | Hodgkin Lymphoma | Osteosarcoma | Acute Lymphoblastic Leukemia | Ewing Sarcoma | Non-Hodgkin Lymphoma | Myelodysplastic Syndrome | Neuroblastoma | Rhabdomyosarcoma | Primitive Neuroectodermal Tumor | Myeloproliferative SyndromeUnited States
-
National Cancer Institute (NCI)CompletedLeukemia | B Cell Lymphoma | Non-Hodgkin Lymphoma | ALL | Large Cell LymphomaUnited States
-
Memorial Sloan Kettering Cancer CenterRecruitingNon-Hodgkin Lymphoma | Non-Hodgkin's Lymphoma, Relapsed | Non-Hodgkin's Lymphoma RefractoryUnited States
-
University of PennsylvaniaTerminated
-
Shenzhen Geno-Immune Medical InstituteThe Second Affiliated Hospital of Hainan Medical UniversityRecruiting
-
University College, LondonDeutsche Krebshilfe e.V., Bonn (Germany); European Union; The Leukemia and Lymphoma... and other collaboratorsTerminatedAcute Lymphoblastic LeukemiaUnited Kingdom, Germany
-
University of PennsylvaniaCompletedAdult Patients Who Have Relapsed or Refractory CLL (3rd Line) or SLLUnited States
-
M.D. Anderson Cancer CenterCompletedLeukemia | Advanced CancersUnited States
-
Children's Hospital of PhiladelphiaUniversity of California, San FranciscoRecruitingImmunodeficiencies | Immune Dysregulation SyndromesUnited States
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdUnknownRefractory Non-Hodgkin Lymphoma | Relapsed Non Hodgkin Lymphoma | CAR - T CD19/CD20/CD22/CD30China
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Glioblastoma | Refractory GlioblastomaUnited States
-
University Health Network, TorontoTakara Bio Inc.RecruitingRelapsed or Refractory Chronic Lymphocytic Leukemia | Relapsed or Refractory Small Lymphocytic Lymphoma | Relapsed or Refractory CD19+ B-cell LymphomaCanada
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingRecurrent Acute Lymphoblastic Leukemia | Refractory Acute Lymphoblastic LeukemiaUnited States
-
Zhu XiaofanRecruitingB Lymphoblastic Lymphoma | B Lymphocytic LeukemiaChina
-
Zhao WeiliShanghai Mingju Biotechnology Co., Ltd.Unknown
-
Stanford UniversityRecruitingLeukemia | Acute Lymphoblastic LeukemiaUnited States
-
Nationwide Children's HospitalRecruitingHematologic Malignancy | Hematopoietic Stem Cell TransplantationUnited States
-
City of Hope Medical CenterNational Cancer Institute (NCI)RecruitingGlioblastoma | Ependymoma | Medulloblastoma | Recurrent Metastatic Malignant Neoplasm in the LeptomeningesUnited States
-
Shenzhen Second People's HospitalUnknownMultiple Myeloma in RelapseChina
-
Ohio State University Comprehensive Cancer CenterMorphoSys AGActive, not recruitingRecurrent Small Lymphocytic Lymphoma | Prolymphocytic Leukemia | Refractory Chronic Lymphocytic Leukemia | Stage III Small Lymphocytic Lymphoma | Stage IV Small Lymphocytic Lymphoma | Stage I Chronic Lymphocytic Leukemia | Stage II Chronic Lymphocytic Leukemia | Contiguous Stage II Small Lymphocytic... and other conditionsUnited States
-
Cancer Research UKAleta BioTherapeuticsRecruitingLymphoma, Follicular | Lymphoma, B-Cell | Lymphoma, Large B-Cell, Diffuse | Lymphoma, Non-Hodgkin | Lymphoma, Mantle-CellUnited Kingdom
-
University of Wisconsin, MadisonUniversity of Wisconsin Carbone Cancer Center (UWCCC)Not yet recruiting
-
First Affiliated Hospital of Harbin Medical UniversityUnknownCD19-chimeric Antigen Receptor T Cells | Relapsed and/or Refractory Acute Lymphoblastic Leukemia | the Haploidentical Hematopoietic Stem Cell TransplantationChina
-
The First Affiliated Hospital of Soochow UniversityShanghai Unicar-Therapy Bio-medicine Technology Co.,LtdRecruitingAcute Lymphoblastic Leukemia With Failed RemissionChina
-
Cedars-Sinai Medical CenterAmgenActive, not recruitingB-ALL | B-Cell Acute Lymphoblastic Leukaemia | ALL, AdultUnited States
-
Memorial Sloan Kettering Cancer CenterNovartis PharmaceuticalsRecruitingB-cell Acute Lymphoblastic LeukemiaUnited States
-
Shanghai Tongji Hospital, Tongji University School...Shanghai AbelZeta Ltd.CompletedB Cell LymphomaChina
-
University of PennsylvaniaNot yet recruiting
-
Hebei Senlang Biotechnology Inc., Ltd.RecruitingAdult B Acute Lymphoblastic LeukemiaChina
-
Baxalta now part of ShireBaxter Innovations GmbHTerminatedHemophilia APoland, United States, Bulgaria, Serbia, Canada, Russian Federation, Germany, Netherlands, Lithuania, Czechia, Austria, Spain
-
Hrain Biotechnology Co., Ltd.Shanghai Changzheng HospitalActive, not recruitingPOMES Syndrome | Relapsed and Refractory POMES SyndromeChina
-
CytoCares IncRecruitingChronic Lymphocytic Leukemia | Non-hodgkin Lymphoma | Acute Lymphoblastic LeukaemiaChina
-
National Taiwan University HospitalUnknown